Valuation: AcuCort AB

Market Cap 115M 11.51M 10.13M 9.57M 8.68M 16.31M 1.11B 16.4M 44.28M 564M 43.22M 42.29M 1.81B P/E 2024
-3.61x
P/E 2025 -5x
Enterprise Value 87.63M 8.8M 7.74M 7.32M 6.64M 12.47M 845M 12.54M 33.84M 431M 33.04M 32.32M 1.39B EV / Sales 2024
129,716,884x
EV / Sales 2025 165,436,272x
Free-Float
66.46%
Yield 2024 *
-
Yield 2025 -
1 day+0.41%
1 week-7.74%
Current month-18.50%
1 month-21.13%
3 months-15.10%
6 months-20.49%
Current year-18.50%
1 week 0.46
Extreme 0.464
0.52
1 month 0.46
Extreme 0.464
0.65
Current year 0.4
Extreme 0.401
0.95
1 year 0.4
Extreme 0.401
0.95
3 years 0.33
Extreme 0.327
1.26
5 years 0.33
Extreme 0.327
4.42
10 years 0.33
Extreme 0.327
9.5
Manager TitleAgeSince
Chief Executive Officer 55 08/08/2020
Corporate Officer/Principal 53 13/10/2025
Director TitleAgeSince
Director/Board Member 68 07/02/2017
Chairman 63 31/12/2017
Director/Board Member 79 31/12/2020
Change 5-day change 1-year change 3-year change Capi.($)
+0.41%-7.74%-15.40%-15.69% 11.51M
+1.31%-2.04%-44.90%-9.34% 14.26B
-1.39%-1.64%-19.32%-8.64% 6.3B
+0.53%-7.34%-54.27%-37.99% 5.82B
+1.77%-1.36%-9.47%-23.55% 3.99B
-0.38%+0.72%-19.79%-37.96% 3.17B
-0.48%+3.36%-40.59%-17.13% 3.02B
+1.25%-3.32%+3.86%-29.06% 2.98B
-1.14%-7.74%+56.27% - 2.61B
+2.38%-0.19%-28.45%-12.45% 2.32B
Average +0.43%-1.51%-17.20%-21.31% 4.45B
Weighted average by Cap. +0.53%-2.25%-27.18%-18.87%

Financials

2024 2025
Net sales 0.68 0.07 0.06 0.06 0.05 0.1 6.51 0.1 0.26 3.32 0.25 0.25 10.67 0.69 0.07 0.06 0.06 0.05 0.1 6.62 0.1 0.27 3.38 0.26 0.25 10.86
Net income -17.4M -1.75M -1.54M -1.45M -1.32M -2.48M -168M -2.49M -6.72M -85.58M -6.56M -6.42M -275M -26.19M -2.63M -2.31M -2.19M -1.98M -3.73M -252M -3.75M -10.11M -129M -9.87M -9.66M -414M
Net Debt -2.77M -278K -245K -232K -210K -394K -26.72M -397K -1.07M -13.64M -1.05M -1.02M -43.82M -27.01M -2.71M -2.39M -2.26M -2.05M -3.84M -260M -3.87M -10.43M -133M -10.18M -9.96M -427M
Logo AcuCort AB
AcuCort AB is a Sweden-based pharmaceutical company. The company develops oral films ISICORT, which involve chemical substance glucocorticoid dexamethasone that is used for the treatment of acute allergic reactions, as well as for nausea and vomiting during chemotherapy treatments. AcuCort AB operates mostly in Nordic countries.
Employees
-
Date Price Change Volume
27/09/26 SEK 0.4890 +0.41% 162,182
25/09/26 SEK 0.4870 -1.22% 208,175
24/09/26 SEK 0.4930 -2.95% 208,008
23/09/26 SEK 0.5080 +3.67% 20,490
22/09/26 SEK 0.4900 -0.20% 82,987
  1. Stock Market
  2. Stocks
  3. ACUC Stock